CRISPR-mediated base editing in hereditary tyrosinemia type 1

Author Information

Nicholas F. Archer, Drexel University College of Medicine, Philadelphia, PAFollow
Cara L. Berkowitz MD, Children's Hospital of Philadelphia, Philadelphia, PA
William H. Peranteau MD, Children's Hospital of Philadelphia, Philadelphia, PA

Keywords:

hereditary tyrosinemia, base editing

Recommended Citation

Archer, Nicholas F.; Berkowitz, Cara L. MD; and Peranteau, William H. MD, "CRISPR-mediated base editing in hereditary tyrosinemia type 1" (2022). Tower Health Research Day. 8.
https://scholarcommons.towerhealth.org/th_researchday/2022/live_posters/8

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not applicable